Notably, DDR1 has been implicated in a signaling pathway that drives breast epithelial differentiation in cooperation with RUNX1, a key regulator of epithelial–mesenchymal transition (EMT) in breast cancer [44]. Here, DDR1 is linked to breast carcinoma.